Mantle cell lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Farima Kahe (talk | contribs) |
||
Line 9: | Line 9: | ||
*There are no established [[risk factors]] for [[mantle cell lymphoma]]. Although, the [[pathogenesis]] of [[mantle cell lymphoma]] at the [[Cellular|cellular level]] is well understood now, there is not enough information on the [[risk factors]] that precipitate the [[cellular]] events. | *There are no established [[risk factors]] for [[mantle cell lymphoma]]. Although, the [[pathogenesis]] of [[mantle cell lymphoma]] at the [[Cellular|cellular level]] is well understood now, there is not enough information on the [[risk factors]] that precipitate the [[cellular]] events. | ||
*However, recently weak associations have been observed in the development of [[mantle cell lymphoma]] with the following: | *However, recently weak associations have been observed in the development of [[mantle cell lymphoma]] with the following: | ||
**With exposure to European strains of Borellia burgdoferi.<ref name="pmid18424667">{{cite journal| author=Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B et al.| title=Borrelia infection and risk of non-Hodgkin lymphoma. | journal=Blood | year= 2008 | volume= 111 | issue= 12 | pages= 5524-9 | pmid=18424667 | doi=10.1182/blood-2007-08-109611 | pmc=2972577 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18424667 }} </ref> | |||
**Family history of [[hematologic]] [[malignancy]].<ref name="pmid17185468">{{cite journal| author=Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L et al.| title=Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). | journal=Blood | year= 2007 | volume= 109 | issue= 8 | pages= 3479-88 | pmid=17185468 | doi=10.1182/blood-2006-06-031948 | pmc=1852242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17185468 }} </ref> | |||
**[[Genetic polymorphisms]] in the [[Proinflammatory|pro-inflammatory]] [[cytokine]] [[IL-10]].<ref name="pmid20047977">{{cite journal| author=Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM et al.| title=Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. | journal=Am J Epidemiol | year= 2010 | volume= 171 | issue= 3 | pages= 267-76 | pmid=20047977 | doi=10.1093/aje/kwp383 | pmc=2842204 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20047977 }} </ref> | |||
==References== | ==References== |
Revision as of 04:54, 3 January 2019
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma risk factors |
Risk calculators and risk factors for Mantle cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
There are no established risk factors for mantle cell lymphoma. However, recently, weak associations have been observed in the development of mantle cell lymphoma with the exposure to European strains of Borellia burgdoferi. family history of hematologic malignancy and genetic polymorphisms in the pro-inflammatory cytokine IL-10.
Risk Factors
- There are no established risk factors for mantle cell lymphoma. Although, the pathogenesis of mantle cell lymphoma at the cellular level is well understood now, there is not enough information on the risk factors that precipitate the cellular events.
- However, recently weak associations have been observed in the development of mantle cell lymphoma with the following:
- With exposure to European strains of Borellia burgdoferi.[1]
- Family history of hematologic malignancy.[2]
- Genetic polymorphisms in the pro-inflammatory cytokine IL-10.[3]
References
- ↑ Schöllkopf C, Melbye M, Munksgaard L, Smedby KE, Rostgaard K, Glimelius B; et al. (2008). "Borrelia infection and risk of non-Hodgkin lymphoma". Blood. 111 (12): 5524–9. doi:10.1182/blood-2007-08-109611. PMC 2972577. PMID 18424667.
- ↑ Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L; et al. (2007). "Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)". Blood. 109 (8): 3479–88. doi:10.1182/blood-2006-06-031948. PMC 1852242. PMID 17185468.
- ↑ Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM; et al. (2010). "Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium". Am J Epidemiol. 171 (3): 267–76. doi:10.1093/aje/kwp383. PMC 2842204. PMID 20047977.